Aralez Pharmaceuticals Inc (ARZ) Insider James Patrick Tursi Sells 9,960 Shares
Aralez Pharmaceuticals Inc (TSE:ARZ) insider James Patrick Tursi sold 9,960 shares of the company’s stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of C$2.50, for a total value of C$24,900.00.
Aralez Pharmaceuticals Inc (TSE:ARZ) traded down 0.96% during trading on Thursday, reaching $3.08. The company had a trading volume of 66,647 shares. The stock has a 50 day moving average of $2.20 and a 200-day moving average of $2.20. The stock’s market capitalization is $205.89 million. Aralez Pharmaceuticals Inc has a 12-month low of $1.46 and a 12-month high of $7.35.
WARNING: This story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/10/05/aralez-pharmaceuticals-inc-arz-insider-james-patrick-tursi-sells-9960-shares.html.
Aralez Pharmaceuticals Company Profile
Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.
Receive News & Stock Ratings for Aralez Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals Inc and related stocks with our FREE daily email newsletter.